Home › Funds › Encore Global Management, LP › BSX
Encore Global Management, LP position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Encore Global Management, LP reported holding 93,700 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 4.51% of its reported portfolio and ranking #3 among its reported holdings. Encore Global Management, LP has disclosed BSX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Encore Global Management, LP's BSX position evolved
Encore Global Management, LP first disclosed a stake in BSX in Q1 2026 at 46,500 shares (US$2.9M). The position peaked in Q3 2026 at 93,700 shares, worth US$4.1M. Across 3 filings, Encore Global Management, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 93,700 shares valued at US$4.1M — an increase of 20,000 shares quarter over quarter.. Notable position changes include a 58% increase in Q2 2026 (shares rose 2% over the following quarter), a 27% increase in Q3 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 46.50K | $2.92M | New |
| Q2 2026 | 73.70K | $3.15M | Add |
| Q3 2026 | 93.70K | $4.09M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 19 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B), Janus Henderson Group (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on Encore Global Management, LP
FAQ
How long has Encore Global Management, LP held BSX?
Encore Global Management, LP has disclosed BSX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Encore Global Management, LP's current position in BSX?
As of Q3 2026, Encore Global Management, LP holds 93.70K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $4.09M, representing 4.51% of its reported portfolio and ranking #3.
Has Encore Global Management, LP been buying or selling BSX?
In the latest 13F filing (Q3 2026), Encore Global Management, LP increased its position in BSX. The position peaked in Q3 2026 at 93.70K shares.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, Janus Henderson Group, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.